BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND STIL, SIL, 6491, ENSG00000123473, Q15468
352 results:

  • 1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Williams-Beuren syndrome in pediatric T-cell acute lymphoblastic leukemia: A rare case report and review of literature.
    Yang R; Ai Y; Bai T; Lu XX; He G
    Medicine (Baltimore); 2024 Feb; 103(7):e36976. PubMed ID: 38363891
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
    Moriki A; Ito S; Horikita F; Tsutsumi Y
    Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation.
    Zhang X; Wang T; Zhang Y; Wang F; Chen J; Ni J; Sun R; Wei Z; Zhang G; Li W; Li J; Lu P
    Leuk Lymphoma; 2023 Dec; 64(13):2133-2139. PubMed ID: 37674391
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Off-the-shelf CAR-engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia.
    Mansour AG; Teng KY; Li Z; Zhu Z; Chen H; Tian L; Ali A; Zhang J; Lu T; Ma S; Lin CM; Caligiuri MA; Yu J
    Blood Adv; 2023 Oct; 7(20):6225-6239. PubMed ID: 37379267
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical features of 19 patients with sil-TAL1-positive T-cell acute lymphoblastic leukemia].
    Wang LJ; Chen Y; Xiang M; Yang XF; Chen SN
    Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):132-136. PubMed ID: 36948867
    [No Abstract]    [Full Text] [Related]  

  • 7. Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling.
    Shah K; Al Ashiri L; Nasimian A; Ahmed M; Kazi JU
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902436
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
    Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
    Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Detection of Fusion Gene and Prognosis Analysis in Children with Acute Lymphoblastic leukemia of Different Immunophenotypes].
    Liu CY; Pan YS; Yang H; Hu X; Chen HY; Liu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1673-1678. PubMed ID: 36476888
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mapping the genetic features of T-ALL cases through simplified NGS approach.
    García-Aznar JM; Alonso S; Iglesias DU; de Ugarriza PL; López CÁ; Balbín M; Del Castillo TB
    Clin Immunol; 2022 Dec; 245():109151. PubMed ID: 36270471
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary Effusion Lymphoma-like ATL Developing during Hemodialysis.
    Masaki M; Okushi Y; Saito A; Fukuda A; Yamada S; Mizuta S; Masaki Y
    Intern Med; 2023 Jun; 62(12):1807-1811. PubMed ID: 36261387
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction.
    Landeira-Viñuela A; Arias-Hidalgo C; Juanes-Velasco P; Alcoceba M; Navarro-Bailón A; Pedreira CE; Lecrevisse Q; Díaz-Muñoz L; Sánchez-Santos JM; Hernández ÁP; García-Vaquero ML; Góngora R; De Las Rivas J; González M; Orfao A; Fuentes M
    Front Immunol; 2022; 13():965905. PubMed ID: 36248816
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.
    Jiang VC; Hao D; Jain P; Li Y; Cai Q; Yao Y; Nie L; Liu Y; Jin J; Wang W; Lee HH; Che Y; Dai E; Han G; Wang R; Rai K; Futreal A; Flowers C; Wang L; Wang M
    Mol Cancer; 2022 Sep; 21(1):185. PubMed ID: 36163179
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis.
    Gao F; Zhang T; Liu H; Li W; Liu X; Qiu L; Li L; Zhou S; Qian Z; Dong S; Zhao S; Wang X; Zhang H
    Ann Hematol; 2022 Nov; 101(11):2383-2392. PubMed ID: 36029326
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic leukemia.
    Yu CH; Wu G; Chang CC; Jou ST; Lu MY; Lin KH; Chen SH; Wu KH; Huang FL; Cheng CN; Chang HH; Hedges D; Wang JL; Yen HJ; Li MJ; Chou SW; Hung CT; Lin ZS; Lin CY; Chen HY; Ni YL; Hsu YC; Lin DT; Lin SW; Yang JJ; Pui CH; Yu SL; Yang YL
    J Mol Diagn; 2022 Nov; 24(11):1195-1206. PubMed ID: 35963521
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
    Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
    [No Abstract]    [Full Text] [Related]  

  • 17. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
    Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
    Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognosis of Indolent Adult T-Cell leukemia/Lymphoma.
    Kameda T; Shide K; Tahira Y; Sekine M; Sato S; Ishizaki J; Takeuchi M; Akizuki K; Kamiunten A; Shimoda H; Toyama T; Maeda K; Yamashita K; Kawano N; Kawano H; Hidaka T; Yamaguchi H; Kubuki Y; Kitanaka A; Matsuoka H; Shimoda K
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458440
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
    Christodoulou I; Ho WJ; Marple A; Ravich JW; Tam A; Rahnama R; Fearnow A; Rietberg C; Yanik S; Solomou EE; Varadhan R; Koldobskiy MA; Bonifant CL
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34896980
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluation of serum levels of selected cytokine receptors in adult B-cell precursor acute lymphoblastic leukemia and their association with prognostic factors and survival.
    Horacek JM; Kupsa T; Vanek J; Jakl M; Stajer M; Jebavy L; Zak P
    Exp Oncol; 2021 Sep; 43(3):234-236. PubMed ID: 34591424
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.